Subacute cutaneous lupus erythematosus induced by chemotherapy: Gemcitabine as a causative agent

JAMA Dermatology

Volumn 149, Issue 9, 2013, Pages 1071-1075

  Wiznia, Lauren E ^a   Subtil, Antonio ^a   Choi, Jennifer N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DESOXIMETASONE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; METHOTREXATE; PACLITAXEL; PREDNISONE; RO ANTIBODY; TAMOXIFEN;

AGED; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COLORECTAL CANCER; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INDUCED DISEASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEMALE; HAND FOOT SYNDROME; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INTRADUCTAL CARCINOMA; LABORATORY TEST; LUNG METASTASIS; LUNG NODULE; METASTASIS RESECTION; MITOSIS INHIBITION; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; MULTIPLE SCLEROSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RASH; SEROLOGY; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; TREATMENT DURATION; UTERUS TUMOR;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; DEOXYCYTIDINE; DRUG ERUPTIONS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS;

EID: 84884678158     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.4957     Document Type: Article

References (20)

1. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol. 1979;115(12):1409-1415. (Pubitemid 10181625)
2. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA. Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med. 1985;103(1):49-51. (Pubitemid 15068498)
3. Fernandes NF, Rosenbach M, Elenitsas R, Kist JM. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy. Arch Dermatol. 2009;145(3):340-341.
4. Floristan U, Feltes RA, Sendagorta E, et al. Subacute cutaneous lupus erythematosus induced by capecitabine. Clin Exp Dermatol. 2009;34(7):e328-e329.
5. Chen M, Crowson AN, Woofter M, Luca MB, Magro CM. Docetaxel (Taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol. 2004;31(4):818-820. (Pubitemid 38451277)
6. Adachi A, Horikawa T. Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody. J Dermatol. 2007;34(7):473-476. (Pubitemid 46956593)
7. Funke AA, Kulp-Shorten CL, Callen JP. Subacute cutaneous lupus erythematosus exacerbated or induced by chemotherapy. Arch Dermatol. 2010;146(10):1113-1116.
8. Guhl G, Diaz-Ley B, García-García C, Fraga J, Garcia-Diez A. Chemotherapy-induced subacute lupus erythematosus. Lupus. 2009;18(9):859-860.
9. Fumal I, Danchin A, Cosserat F, Barbaud A, Schmutz JL. Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases. Dermatology. 2005;210(3):251-252. (Pubitemid 40529249)
10. Grönhagen CM, Fored CM, Linder M, Granath F, Nyberg F. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. Br J Dermatol. 2012;167(2):296-305.
11. Lowe G, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011;164(3):465-472.
12. Marzano AV, Vezzoli P, Crosti C. Drug-induced lupus: an update on its dermatologic aspects. Lupus. 2009;18(11):935-940.
13. Furukawa F. Antinuclear antibody-keratinocyte interactions in photosensitive cutaneous lupus erythematosus. Histol Histopathol. 1999;14(2):627-633. (Pubitemid 29159030)
14. Stollar BD, Stephenson F. Apoptosis and nucleosomes. Lupus. 2002;11(12):787-789. (Pubitemid 36069972)
15. Weger W, Kränke B, Gerger A, Salmhofer W, Aberer E. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine. J Am Acad Dermatol. 2008;59(2)(suppl 1):S4-S6. (Pubitemid 351952412)
16. Almagro BM, Steyls MC, Navarro NL, et al. Occurrence of subacute cutaneous lupus erythematosus after treatment with systemic fluorouracil. J Clin Oncol. 2011;29(20):e613-e615.
17. Pham AQ, Berz D, Karwan P, Colvin GA. Cremophor-induced lupus erythematosus-like reaction with Taxol administration: a case report and review of the literature. Case Rep Oncol. 2011;4(3):526-530.
18. McLean DI. Cutaneous paraneoplastic syndromes. Arch Dermatol. 1986;122(7):765-767. (Pubitemid 16093279)
19. Chaudhry SI, Murphy LA, White IR. Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis? Clin Exp Dermatol. 2005;30(6):655-658. (Pubitemid 41499821)
20. Callen JP. Drug-induced subacute cutaneous lupus erythematosus. Lupus. 2010;19(9):1107-1111.